Form 4: Integra LifeSciences Executive Eric Schwartz Reports Changes in Beneficial Ownership

Eric Schwartz, EVP, Chief Legal Officer & Secretary of Integra LifeSciences, reports disposition of common stock to cover tax obligations.

Summary

• On March 11, 2025, Eric Schwartz, EVP, Chief Legal Officer & Secretary of Integra LifeSciences, reported changes in beneficial ownership of the company's common stock.
• The transactions involved the disposition of 1,538 and 1,180 shares of common stock at a price of $23.95 per share.
• These dispositions were likely to cover tax obligations related to vesting of stock awards.
• Following the reported transactions, Schwartz beneficially owns 56,020 shares of Integra LifeSciences common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The disposition of shares by an executive could be perceived neutrally or slightly negatively by shareholders, depending on the context and the overall market sentiment.

Key Dates